Evotec
(NASDAQ:EVO)
Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share is expected to split Monday, August 15, 2022 with a ratio of 1:5
Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share recently split on Friday, August 12, 2022 with a ratio of 1:3
$13.97
0.83[6.32%]
At close: Aug 12
$13.97
After Hours: 4:00PM EDT
Day High/Low13.62 - 13.97
52 Week High/Low10.6 - 23.63
Open / Close13.65 / 13.97
Float / Outstanding- / 353.9M
Vol / Avg.109.1K / 33.1K
Mkt Cap4.9B
P/E678.23
50d Avg. Price13.01
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float281.9M

Evotec (NASDAQ:EVO), Quotes and News Summary

Evotec (NASDAQ: EVO)

Day High/Low13.62 - 13.97
52 Week High/Low10.6 - 23.63
Open / Close13.65 / 13.97
Float / Outstanding- / 353.9M
Vol / Avg.109.1K / 33.1K
Mkt Cap4.9B
P/E678.23
50d Avg. Price13.01
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float281.9M
Sector: Health Care.Industry: Life Sciences Tools & Services
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Evotec Questions & Answers

Q
How do I buy Evotec (EVO) stock?
A

You can purchase shares of Evotec (NASDAQ: EVO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Evotec's (EVO) competitors?
Q
What is the target price for Evotec (EVO) stock?
A

The latest price target for Evotec (NASDAQ: EVO) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting EVO to fall to within 12 months (a possible -71.37% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Evotec (EVO)?
A

The stock price for Evotec (NASDAQ: EVO) is $13.97 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Evotec (EVO) pay a dividend?
A

The next Evotec (EVO) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Evotec (NASDAQ:EVO) reporting earnings?
A

Evotec’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Evotec (EVO) going to split?
A

There is no upcoming split for Evotec.

Q
What sector and industry does Evotec (EVO) operate in?
A

Evotec is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.